A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Dr
RecruitingNCT06388707Phase: PHASE1, PHASE2Started 2024-09-13
Summary
This will be a prospective, open-label, single-arm, multi-center, pilot study to evaluate the safety, tolerability, and preliminary efficacy of low-intensity focused ultrasound (LIFU) neuromodulation
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
None
Locations
Stanford University School of MedicinePalo Alto, California, United States
Brigham and Women's HospitalBoston, Massachusetts, United States
University of Virginia School of MedicineCharlottesville, Virginia, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06388707